Table 1

Patient baseline characteristics, treatments, and outcomes

InterventionP value
FFP (n=25)PCC (n=27)
Age*83.8 (6.51)85.8 (7.10)0.290
Number of females (%)†16 (64)10 (37)0.096
Number of white patients (%)†22 (88)27 (100)0.208
Congestive heart failure†1 (4)3 (11)0.336
History of falls (%)†9 (36.0)11 (40.7)0.725
Glasgow Coma Scale (SD)*14.32 (2.44)14.04 (2.70)0.693
Injury Severity Score (SD)*15.72 (4.08)16.93 (5.57)0.375
AIS-Head and Neck (SD)*3.64 (0.70)3.85 (0.72)0.287
Initial scan
 Subdural hematoma (%)14 (56)21 (78)
 Subarachnoid hemorrhage6 (24)2 (7)
 Intraparenchymal hemorrhage (%)4 (16)7 (26)
Infusion volume, mL (SD)*910 (370)87 (33)<0.001‡
Neurointervention (%)†2 (8.0)3 (11.1)0.704
Mortality (%)*0 (0.0)3 (11.1)0.262
Hospital LOS, days (SD)*4.16 (2.56)3.73 (1.42)0.335
Admitted to ICU (%)†17 (68)21 (78)0.630
ICU LOS, days (SD)*2.29 (1.16)2.43 (0.68)0.676
Proportion that reached INR <1.5 within 8 hours (%)†4/14 (29)17/21 (81)0.002‡
CT progression within 24 hours (%)†5/14 (36)10/23 (43)0.365
  • *Pearson’s χ2 test.

  • †Two-sample t-test assuming equal variance.

  • ‡Significant result

  • AIS, Abbreviated Injury Scale; FFP, fresh frozen plasma; ICU, intensive care unit; INR, international normalized ratio; LOS, length of stay; PCC, prothrombin complex concentrate.